The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
Stephen B. Willingham(Silvus Technologies (United States)), Irving L. Weissman(California Institute for Regenerative Medicine)
Cited by 1,650
Related Papers
Stem cells, cancer, and cancer stem cells
|Nature|2001|9.7k
Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
|Nature|2017|2.3k
Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CML
|New England Journal of Medicine|2004|1.5k
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
|Journal of Clinical Oncology|2019|590